Seven pharmaceutical companies seeking to make generic versions of Crestor have challenged the validity and enforceability of AstraZeneca's patent on the drug.
Who has first-filer status on this one?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”